Insulin pumps in diabetes

Attention: open in a new window. | Print | E-mail

Clinical Focus

Written by Dr Colin Davenport and Dr Diarmuid Smith Monday, 08 March 2010 15:55

Insulin pump therapy is being increasingly employed in the management of type 1 diabetes, write Dr Colin Davenport and Dr Diarmuid Smith.

 

Oesophageal cancer update

Attention: open in a new window. | Print |

Clinical Focus

Written by Mr Robert Stuart Monday, 22 February 2010 12:20

To coincide with this year’s Lollipop Day, consultant surgeon Mr Robert Stuart provides an update on this devastating cancer.

 

Resisting the solution

Attention: open in a new window. | Print | E-mail

Clinical Focus

Written by Dr Jack Lambert Friday, 22 January 2010 12:57

Clear leadership and guidance are needed before the issue of hospital-acquired infections can be properly dealt with, writes infectious disease specialist Dr Jack Lambert.

   

The treatment of major depressive disorder

Attention: open in a new window. | Print | E-mail

Clinical Focus

Written by Dr Seán Ó Domhnaill and Dr Zorina Gibbons Friday, 15 January 2010 14:31

The treatment of depression is now entering its third age. From the serendipitous discovery of the antidepressant effects of the anti-tubercular medications rose the Monoamine Hypothesis of depression. This theory, that depression was the result of a reduced availability of the monoamines serotonin, noradrenaline and (less markedly) dopamine, led to the development of agents that could increase the availability of the aforementioned intra-synaptic monoamine neurotransmitters.

 

Electroconvulsive therapy for depression treatment

Attention: open in a new window. | Print | E-mail

Clinical Focus

Written by Professor Declan McLoughlin Thursday, 10 December 2009 12:53

Major depression is a serious psychiatric disorder with a high relapse rate. Up to 30 per cent of patients have treatment resistant depression and fail to respond to antidepressant drugs and psychotherapies.  However, for such patients remission rates following electroconvulsive therapy (ECT) are as high as 80 per cent.

   

Page 1 of 12